Biosimilar Development solution center
-
Thunderstruck By Antibody-Drug Conjugates
3/18/2025
Antibody-drug conjugates are transforming cancer treatment by targeting tumors directly to reduce side effects. Discover how they affect neighboring cells, which can enhance treatment efficacy and eliminate tumor cell populations.
-
The Patent Cliff Looms – Design Your Biosimilar Approach Accordingly
3/3/2025
In your pursuit of developing a high-quality biosimilar, think strategically. Consider what type of biologic your team’s expertise can support and which is needed most in your target market.
-
U.S. Biosimilars Surge: Clinical Trials, Regulatory Shifts, And The Path To Dominance
2/28/2025
Joseph Pategou asks and answers, "Where does the U.S. biosimilar market stand now?"
-
Multi-Attribute Method Analysis In Biopharmaceutical Development
2/26/2025
Analytics is a crucial element in biopharmaceutical development and manufacturing. Discover how Multi-Attribute Method (MAM) revolutionizes analytics to enhance quality control and regulatory compliance.
-
Emerging Trends In mAbs Manufacturing In 2025 And Beyond
2/11/2025
Two key innovations — continuous perfusion in upstream processing and multicolumn chromatography in downstream processing — are having a profound impact on biologics manufacturing.
-
Clinical Regulatory Changes One Of Many Tailwinds For Biosimilars
2/10/2025
With an projected global market value of $35.7 billion in 2025, biosimilars are slated for considerable growth opportunities, thanks in part to clinical regulatory changes.
-
Improving Bioprocess Monitoring And Control With Multivariate Data Analysis
12/9/2024
Learn about multivariate data analysis (MVDA) techniques, like PCA and PLS, that enable near real-time monitoring, prediction, and optimization of biomanufacturing processes.
-
Optimize Your RFP To Ensure Successful Biologic Development
11/5/2024
Creating a thorough, comprehensive RFP will help a CDMO partner lay the foundation for a productive partnership, fulfill your goals, and help ensure future market success for your therapeutic.
-
Choose The Right CDMO To Guide Your Biologic To Regulatory Success
11/5/2024
If you are wondering when to begin your CDMO search, the answer is simple: the sooner the better. Partnering with a CDMO early helps ensure later success.
-
3 Ways To Maximize The Benefits Of Your CDMO Partnership
11/5/2024
An experienced CDMO partner can help bridge the gap from lab scale to clinical and commercial scale while sharing the critical insights needed to launch a biologic manufacturing program.